Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000072

EVP Research sold 9,933 shares at an average $75.34 ($748,383)

  • EVP Research acquired 21,477 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Swayze Eric · EVP Research

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-15 Exercise or conversion : show line 1 in the form +21,366 51,819 D
2026-01-16 Sale : show line 2 in the form −9,884 $75.34 $744,661 41,935 D
2026-01-15 Exercise or conversion : show line 3 in the form +111 367 I
2026-01-16 Sale : show line 4 in the form −49 $75.97 $3,723 318 I
Open-market sales · 9,933 sh · avg $75.34 · $748,383

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2026-01-15 Grant or award : show line 5 in the form Performance Restricted Stock Units +25,800 90,282 D
2026-01-15 Exercise or conversion : show line 6 in the form Restricted Stock Unit −21,366 39,251 D
2026-01-15 Grant or award : show line 7 in the form Restricted Stock Unit +9,675 48,926 D
2026-01-15 Exercise or conversion : show line 8 in the form Restricted Stock Unit −111 386 I
2026-01-15 Grant or award : show line 9 in the form Restricted Stock Unit +225 611 I
Loading xslF345X05/edgardoc.xml…